<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43"><gtr:id>31BAAEA1-1BCB-4D42-B1B3-4FC2539E6F43</gtr:id><gtr:name>Public Health England</gtr:name><gtr:address><gtr:line1>Porton Down</gtr:line1><gtr:line4>Salisbury</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SP4 0JG</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/869F0B29-11C9-4722-9E9E-205F6BC4F56D"><gtr:id>869F0B29-11C9-4722-9E9E-205F6BC4F56D</gtr:id><gtr:name>Tecan UK Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/33735849-D455-4914-AB52-D4E0A8F67091"><gtr:id>33735849-D455-4914-AB52-D4E0A8F67091</gtr:id><gtr:name>Pluriomics BV</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A400BE25-0A67-4DC4-90E2-F3C57C400F4D"><gtr:id>A400BE25-0A67-4DC4-90E2-F3C57C400F4D</gtr:id><gtr:name>Technion Israel Institue of Technology</gtr:name><gtr:address><gtr:line1>Taub Building</gtr:line1><gtr:line2>Technion  Institute of Technology</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BC0E951E-239C-4369-8E5A-6E82F9B06B50"><gtr:id>BC0E951E-239C-4369-8E5A-6E82F9B06B50</gtr:id><gtr:name>University of Leiden</gtr:name><gtr:address><gtr:line1>P.O. Box 9506</gtr:line1><gtr:line4>Leiden</gtr:line4><gtr:line5>2300</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/42B56A32-9194-468C-A790-BE55133838A6"><gtr:id>42B56A32-9194-468C-A790-BE55133838A6</gtr:id><gtr:name>University of Hamburg</gtr:name><gtr:address><gtr:line1>ZMK</gtr:line1><gtr:line2>Blunderstrasse</gtr:line2><gtr:line4>Hamburg</gtr:line4><gtr:line5>20146</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9D53091E-603E-4B64-B5EC-6430D28827FD"><gtr:id>9D53091E-603E-4B64-B5EC-6430D28827FD</gtr:id><gtr:name>Syngenta</gtr:name><gtr:address><gtr:line1>WRO-1004.1.51</gtr:line1><gtr:line2>Schwarzwaldallee 215</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Switzerland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6D93C4B4-6A1A-4858-8A69-03438AAFF1FC"><gtr:id>6D93C4B4-6A1A-4858-8A69-03438AAFF1FC</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Denning</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A398B4B7-4241-4DF2-832E-097103A0A371"><gtr:id>A398B4B7-4241-4DF2-832E-097103A0A371</gtr:id><gtr:firstName>Lorraine</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Young</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FG021821%2F1"><gtr:id>F2F936C4-73AD-44D3-9922-86004FAB7F5E</gtr:id><gtr:title>Stem cell screening of human nutrient-gene interactions at the epigenetic level</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G021821/1</gtr:grantReference><gtr:abstractText>Scientific evidence indicates that the nutrients supplied by a pregnant mother to her fetus can influence genes in ways that may alter how fetal organs develop during pregnancy. This may lead to a range of later life diseases when her baby becomes an adult (including obesity, heart disease and diabetes). Mum's diet during pregnancy could affect the fertility of her children and perhaps even induce diseases that not only affect the mother's children but also her grandchildren and future generations. Studies have suggested that nutrients that can determine whether a specific gene is switched on or off at a time when specific organs are being formed may underlie how diet can alter development and cause disease. Each organ formed (such as the liver, heart and kidney's) requires a certain set of genes to be switched on or off at the correct time in development, This ensures that, for example, 'kidney' genes are not incorrectly switched on when the heart is being formed. This project aims to determine which combinations of nutrients may alter the chemistry of DNA to determine whether genes are properly or incorrectly turned on or off. These so-called 'epigenetic' changes could be 'good' or 'bad' at promoting healthy development. How nutrients affect the epigenetic chemistry of genes is not routinely assessed at present by the food industry, mainly because it is obviously not possible to experimentally feed pregnant women potentially damaging diets and other methods for assessing human cells have not yet been developed. Syngenta, other food companies and Governmental agencies who regulate food safety are aware of the potential for epigenetic effects that, if detected, could avoid some diseases. If they knew what type of safe foodstuffs to develop, or to advise us what is safest to eat, they could assist in improving the nations's health. There is now a need for developing an industrially-relevant tool that would allow us to robotically screen the many potential combinations and amounts of different foodstuffs that could affect our genes. This need has prompted our collaboration between the University of Nottingham and Syngenta, that also builds on the previous BBSRC funded work in Nottingham. The project will use human embryonic stem cells and liver cells derived from them to investigate the impact of nutrients and food additives on two human tissues that may be very susceptible to nutrient exposure. Before the availability of human embryonic stem cells, it was not possible to carry out routine experiments of this nature on the human embryo or liver. The embryo is of importance since major epigenetic changes occur in almost all genes at this stage as the embryo is about to make all of the cell types necessary to construct a fetus. It is well-documented in several mammals that embryonic cells are particularly vulnerable to epigenetic disruption that can profoundly alter development and lead to adult disease and so early pregnancy is an important time to assess. The liver is likely to be the organ of major importance in the fetus and adult, since 1) it is known to be the major site of producing chemical methyl groups to make epigenetic changes to genes 2) nutrients obtained from the diet are often converted to other chemical variants by the liver and so the liver may unravel diet-induced changes that are more likely to occur in the body, rather than in cells simply cultured in the laboratory.</gtr:abstractText><gtr:technicalSummary>Increasingly epigenetic processes are being recognised as significant mediators of dietary programming, on subsequent health not only in individuals but in their offspring and even their offspring's progeny. The exact nature of these epigenetic processes and the nutrients that induce them remains a 'black box'. Due to the lack of a tractable human system to investigate the underlying mechanisms, this Industrial Partnership between the University of Nottingham and Syngenta aims to investigate the suitability of human embryonic stem cells (hESC) and their hepatocyte derivatives as novel platforms for assessing the epigenetically-based benefits and risks of micro-nutrients. The project will focus on nutrients that contribute to the methionine/folate metabolic cycles that are particularly active in embryonic cells and hepatocytes, since these cycles produce the methyl groups required for DNA and histone methylation. Using high throughput cell culture screens, a wide range of nutrient dose and exposure time combinations can be evaluated on a scale not previously possible. Combined with high throughput sequencing evaluation of the epigenome, comprehensive analysis of the nature and extent of nutritional programming on epigenetic methylation reactions will be evaluated. This will inform optimal dietary choices for improved health and provide industrially-relevant tools to help develop new foodstuffs in the biosafe manner that Government regulators require increasingly.</gtr:technicalSummary><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-09-28</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1001328</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>6C370E2E-F0C0-4157-8DFC-D73F63E1A28D</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>5C264858-C1EF-4FF3-8434-468805281C04</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pluriomics BV</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>90562E2D-8D92-4015-8920-437D44818E3A</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Institute for Biological Standards and Control (NIBSC)</gtr:department><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>A2B838B0-BF99-4C2A-8436-3AFB55A35A90</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Syngenta</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>syngenta</gtr:description><gtr:id>2C281A73-8F0C-4FD2-8336-8FB81B253033</gtr:id><gtr:impact>advances in stem cell automation</gtr:impact><gtr:partnerContribution>intellectual and financial input</gtr:partnerContribution><gtr:piContribution>stem cell automation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>2D04FA71-7AFB-4878-A563-0E3FEF6C88C6</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tecan UK Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Automation (Development of robot)</gtr:description><gtr:id>8102946F-00C8-4C69-A30F-214833804205</gtr:id><gtr:impact>Publications, grants</gtr:impact><gtr:partnerContribution>Role in automation</gtr:partnerContribution><gtr:piContribution>Bespoke robotic platform for automated culture and differentiation of human stem cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>491CE468-81A4-4A01-B33B-B230BF912452</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technion - Israel Institute of Technology</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>BIRAX interactions (Mummery, Gepstein)</gtr:description><gtr:id>184E6DCA-055F-40AC-96E6-BD74E9DC88B7</gtr:id><gtr:impact>Early stage at present</gtr:impact><gtr:partnerContribution>Skills in progenitor cell biology and cell transplantation in vivo</gtr:partnerContribution><gtr:piContribution>New partnership between three labs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy Nottingham</gtr:department><gtr:description>surface work (Morgan Alexander, Nottingham)</gtr:description><gtr:id>4F9A22B9-AD7A-4E13-A75D-315B11B1DC26</gtr:id><gtr:impact>grants and papers</gtr:impact><gtr:partnerContribution>Multiple grant awards and papers</gtr:partnerContribution><gtr:piContribution>lead the stem cell work of this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>MRC-TEL consortium (Manchester, UKSCB, Sanger, TEL)</gtr:description><gtr:id>D81AAD93-8AFD-4182-BE1B-549F71E11AEF</gtr:id><gtr:impact>joint grant with industrial partner</gtr:impact><gtr:partnerContribution>joint grant with industrial partner</gtr:partnerContribution><gtr:piContribution>joint grant with industrial partner</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>1DF0E06F-21F0-4EEB-BA77-81B7608812DA</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hamburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>3FA99A27-49D9-4F1F-974A-0A502BB3E8FA</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Safety Assessment GSK</gtr:department><gtr:description>Industrial collaboration (GSK via CRACK-IT)</gtr:description><gtr:id>06C02F8A-77DC-4F56-AE80-30B9ED49A3A3</gtr:id><gtr:impact>Financial, international collaboration, skills sharing, joint PhD students, researcher exchange</gtr:impact><gtr:partnerContribution>Implicit in the sponsorship and construction of the challenge</gtr:partnerContribution><gtr:piContribution>Facilitated award of NC3Rs CRACK-IT grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen Mary College</gtr:department><gtr:description>Maturation grant (Tinker, Smith, Fischer)</gtr:description><gtr:id>8F1C6A96-0B2A-473B-A1EA-6B44A6913A4A</gtr:id><gtr:impact>joint grant and development of equipment, new molecules, cell resources</gtr:impact><gtr:partnerContribution>joint grant and development of equipment, new molecules, cell resources</gtr:partnerContribution><gtr:piContribution>joint grant and development of equipment, new molecules, cell resources</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CRACK-IT consortium</gtr:description><gtr:id>EB9A1DD0-5EA3-450D-AA06-5D2C4DA5FED0</gtr:id><gtr:impact>publications and grants</gtr:impact><gtr:partnerContribution>all active contributors to researcher and academic input</gtr:partnerContribution><gtr:piContribution>consortium working on safety assessment</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Various presentations that Lisa, Yan and Roger did for BBSRC projects</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D7E371C6-EDF0-4719-9581-46D1BFC614B4</gtr:id><gtr:impact>Presentations, workshops, posters, industrial engagement</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? MRC grant MR/M017354/1: MICA: Development of Metrics and Quality Standards for Scale up of Human Pluripotent Stem Cells. 1.5.15-30.4.17 &amp;pound;1.</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>80F01123-8F93-47C9-9850-BBCC54E08D63</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Special Project no. SP/15/9/31605. &amp;quot;Coupling gene targeted reporters with fully automated compound library screening to mature hPSC-cardiomyocytes&amp;quot;.</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>SP/15/9/31605</gtr:fundingRef><gtr:id>D0BE972D-CCDA-4B8D-BE39-A4D437704E08</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 1</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>72451B5D-EDDD-4622-9A40-C86C5D33D001</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Asha E-term fellowship</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>F8EC1460-7178-475C-B1FF-CEA90AE241BA</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC equip - seahorse</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>88D1A6D3-E738-4B93-91E6-349C99344002</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF programme 2014-17</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>C4B7332F-8619-4D76-A616-3E34327EE2D9</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BHF Programme Grant RG/15/6/31436: Predicting anti-arrhythmic drug efficacy from the divergent molecular basis of RyR2 dysfunction in genetic arrhythmia syndromes</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/15/6/31436</gtr:fundingRef><gtr:id>E88FD711-1D44-49DD-B55E-58783C4831F2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre for Regen Med</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>P47352/</gtr:fundingRef><gtr:id>ADF6EBF7-FF26-4617-A357-213290E58DB3</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Impact Accelerator Award. A Strategic Partnership with the Australian Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) to Commercialise Stem Cell Culture Polymers</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>80C5EDDE-F486-4DDE-BEE4-7D75529CB397</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs main panel (Viola)</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>NC/K000225/1</gtr:fundingRef><gtr:id>61FEC34E-441A-4557-B63C-E23BD35950E5</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? EPSRC Programme Grant EP/N006615/1: 'Next Generation Biomaterials Discovery'. PI: Morgan Alexander. Multiple Co-Is. 1.10.15-30.9.20. &amp;pound;6.6m</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/N006615/1</gtr:fundingRef><gtr:id>5DEDEB7B-71FA-4739-A7FF-7423482FFC63</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>? BIRAX grant 04BX14CDLG. Gene targeted optogenetics in hPSC-cardiovascular cells for transplantation into animal models of heart dysfunction. 1.9.15-31.8.18. &amp;pound;400K</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:fundingRef>04BX14CDLG</gtr:fundingRef><gtr:id>21B2C060-8BBB-4F2E-A174-6176F8442C94</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU - dave</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>D0867908-9C57-4192-8C88-0C66AA126F6F</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>714000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC capital equipment</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L012618/1</gtr:fundingRef><gtr:id>36A8CC2C-653B-4C8C-BE4F-A05FBA42BB3F</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF MyoD grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/14/59/31000</gtr:fundingRef><gtr:id>0E69139C-BCA6-4D7A-A169-15E2865CE0AE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>602000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Nottingham Strategic Development Fund &amp;quot;Nottingham Regenerative Medicine Centre&amp;quot; 1.1.15-31.12.18. &amp;pound;602,140 (PI)</gtr:description><gtr:end>2020-10-02</gtr:end><gtr:fundingOrg>University of Nottingham</gtr:fundingOrg><gtr:fundingRef>n/a</gtr:fundingRef><gtr:id>0CAD20D4-211E-40BE-9EF1-08B102E2ADCE</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>475000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Programme Grant (2 pilot with Sian Harding)</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG/11/19/29264</gtr:fundingRef><gtr:id>6BBE28AA-02BA-44F9-814E-4096C2887665</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>147000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Heart Res UK (Divya)</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Heart Research UK</gtr:fundingOrg><gtr:fundingRef>TRP01/12</gtr:fundingRef><gtr:id>DED891AA-8381-4B8B-BF8D-BDA9C967F1CF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NC3Rs-CRACK-IT phase 2</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:id>EA6C0B8C-B6FE-4F78-8F78-C2B66F06A41F</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>A final report was submitted to BBSRC by the PI. I do not have access to this as the PI left the university 2 years ago</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>24DB45EE-A858-4832-82D9-D8C32D9916DC</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>robotic platform developed to secure academic and industrial collaborations e.g with Syngenta, GSK and Tokyo Electron</gtr:description><gtr:exploitationPathways>academic and industrial collaborations</gtr:exploitationPathways><gtr:id>CBC54540-ECDE-40D5-920B-2A2789B2DD60</gtr:id><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20057D04-BD10-436C-AD39-6650AE7494E1"><gtr:id>20057D04-BD10-436C-AD39-6650AE7494E1</gtr:id><gtr:title>Exon skipping and gene transfer restore dystrophin expression in hiPSC-cardiomyocytes harbouring DMD mutations.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d0a82c1753617d519e42ca31d6631d0a"><gtr:id>d0a82c1753617d519e42ca31d6631d0a</gtr:id><gtr:otherNames>Dick E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82944957-1029-4BF5-919F-F4E96719F998"><gtr:id>82944957-1029-4BF5-919F-F4E96719F998</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE921029-2D6F-4B9C-A6B5-8F3F531885B9"><gtr:id>CE921029-2D6F-4B9C-A6B5-8F3F531885B9</gtr:id><gtr:title>Scaling human pluripotent stem cell expansion and differentiation: are cell factories becoming a reality?</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3ee80f93fb699e3ce06d44043a7ef99d"><gtr:id>3ee80f93fb699e3ce06d44043a7ef99d</gtr:id><gtr:otherNames>Smith JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/488AF9C5-ECD2-4148-A641-38F793C5BF00"><gtr:id>488AF9C5-ECD2-4148-A641-38F793C5BF00</gtr:id><gtr:title>A defined synthetic substrate for serum-free culture of human stem cell derived cardiomyocytes with improved functional maturity identified using combinatorial materials microarrays.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15f5a65ec20558965fa2d27363b8d946"><gtr:id>15f5a65ec20558965fa2d27363b8d946</gtr:id><gtr:otherNames>Patel AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D74A2A4-7324-4EBE-BA5C-40528E60F87F"><gtr:id>0D74A2A4-7324-4EBE-BA5C-40528E60F87F</gtr:id><gtr:title>In vitro uses of human pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/04C32C33-8920-48D2-910C-A970FC41EE22"><gtr:id>04C32C33-8920-48D2-910C-A970FC41EE22</gtr:id><gtr:title>Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1dc533ec61bcb06d365d185e0dabeb1f"><gtr:id>1dc533ec61bcb06d365d185e0dabeb1f</gtr:id><gtr:otherNames>Denning C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD15412E-B658-4246-8F2A-F95F7B926F65"><gtr:id>DD15412E-B658-4246-8F2A-F95F7B926F65</gtr:id><gtr:title>High throughput screening for discovery of materials that control stem cell fate</gtr:title><gtr:parentPublicationTitle>Current Opinion in Solid State and Materials Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d87383292ff314baabba8e48b3e9fc3a"><gtr:id>d87383292ff314baabba8e48b3e9fc3a</gtr:id><gtr:otherNames>Patel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D9D4D43-11E5-45EE-8A00-DEBD691C0526"><gtr:id>7D9D4D43-11E5-45EE-8A00-DEBD691C0526</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A5AB32B-00C2-475F-B2A2-D147BA3F452A"><gtr:id>4A5AB32B-00C2-475F-B2A2-D147BA3F452A</gtr:id><gtr:title>Discovery of a Novel Polymer for Human Pluripotent Stem Cell Expansion and Multilineage Differentiation.</gtr:title><gtr:parentPublicationTitle>Advanced materials (Deerfield Beach, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71778760bcfbaedc02a6e2939f7135ca"><gtr:id>71778760bcfbaedc02a6e2939f7135ca</gtr:id><gtr:otherNames>Celiz AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0935-9648</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16FE04CA-58FF-4E67-BD07-E1F45200611E"><gtr:id>16FE04CA-58FF-4E67-BD07-E1F45200611E</gtr:id><gtr:title>Current status of drug screening and disease modelling in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9281257D-858B-4A4B-AE36-1930D23DFCDB"><gtr:id>9281257D-858B-4A4B-AE36-1930D23DFCDB</gtr:id><gtr:title>Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/295ffa75c27b1791106e9b65b0baa8fc"><gtr:id>295ffa75c27b1791106e9b65b0baa8fc</gtr:id><gtr:otherNames>Rajamohan D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C670D9ED-FB64-4FD4-B0D1-FCCAD785CD36"><gtr:id>C670D9ED-FB64-4FD4-B0D1-FCCAD785CD36</gtr:id><gtr:title>Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c737bf77ff2d19310dc6d3e68481b0fd"><gtr:id>c737bf77ff2d19310dc6d3e68481b0fd</gtr:id><gtr:otherNames>Matsa E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B2B61FEC-1DDF-4754-A90C-8F8119EC1D51"><gtr:id>B2B61FEC-1DDF-4754-A90C-8F8119EC1D51</gtr:id><gtr:title>Identification of polymer surface adsorbed proteins implicated in pluripotent human embryonic stem cell expansion.</gtr:title><gtr:parentPublicationTitle>Biomaterials science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/12624f7c7748d454dbff9720d6c307a4"><gtr:id>12624f7c7748d454dbff9720d6c307a4</gtr:id><gtr:otherNames>Hammad M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4830</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DD7E12F-FE14-441E-9E2C-36A615A50478"><gtr:id>9DD7E12F-FE14-441E-9E2C-36A615A50478</gtr:id><gtr:title>Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7f098469dc1dbb18dc75ff4bb9372c1b"><gtr:id>7f098469dc1dbb18dc75ff4bb9372c1b</gtr:id><gtr:otherNames>Goldring C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G021821/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>